Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterizing CFTR modulated sweat chloride response across the cf population: Initial results from the CHEC-SC study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society - 1 Jan 2023

Mayer-Hamblett N, Zemanick E T, Odem-Davis K, VanDevanter D, Warden M, Rowe S M, Young J, Konstan M W, For-The-Chec-Sc-Study-Group

Abstract excerpt

BACKGROUND: CHEC-SC is an ongoing epidemiologic study characterizing modulator-induced sweat chloride (SC) responses across the CF population, with interim results available prior to the availability of triple combination modulator therapy. METHODS: Eligible participants had been prescribed a modulator for ≥90 days with re-enrollment allowed upon establishment of a new modulator. Pre-modulator SC values were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Benzodioxoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chloride Channel Agonists

Share to Chlorides

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Drug Combinations

Source

Open in PubMed Open full text

Identifiers

PMID: 35871974
DOI: 10.1016/j.jcf.2022.07.008
PMCID: PMC10103635

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterizing CFTR modulated sweat chloride response across the cf population: Initial results from the CHEC-SC study.PMID 35871974Read ↗

Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis.Semantic proximity Read ↗

Real-world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis.Semantic proximity Read ↗

Genotype-dependent biochemical response to elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis: A 24-month real-world study.Semantic proximity Read ↗

Impact of CFTR modulator concentrations on clinical response in cystic fibrosis.Semantic proximity Read ↗

Contributors to the heterogeneity of response to CFTR modulators.Semantic proximity Read ↗

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.Semantic proximity Read ↗

INTEGRATING GENOMIC AND FUNCTIONAL TESTING TO IMPROVE CFTR MODULATOR RESPONSE PREDICTION IN CHILDREN WITH CYSTIC FIBROSISSemantic proximity Read ↗

Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation.Semantic proximity Read ↗

Advancing clinical development pathways for new CFTR modulators in cystic fibrosis.Semantic proximity Read ↗

Real-World Clinical Outcomes of Lumacaftor-Ivacaftor or Tezacaftor-Ivacaftor Therapy in Children With Cystic Fibrosis Homozygous for Phe508del.Semantic proximity Read ↗

Predictive capacity of paediatric nasal epithelial cells in sequential CFTR modulator therapy.Semantic proximity Read ↗

Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical Trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.